๐Ÿ’ฅ๐—•๐—ฅ๐—˜๐—”๐—ž๐—œ๐—ก๐—š ๐—ก๐—˜๐—ช๐—ฆ๐Ÿ’ฅ ๐—œ๐— ๐——๐—ฅ๐—™ ๐—ก๐Ÿฐ๐Ÿณ & ๐—ก๐Ÿฑ๐Ÿฎ recently updated to ๐—˜๐—ฑ๐—ถ๐˜๐—ถ๐—ผ๐—ป ๐Ÿฎ โ€“ ๐—ช๐—ต๐—ฎ๐˜โ€™๐˜€ ๐˜๐—ต๐—ฒ ๐—ฟ๐—ฒ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ต๐—ถ๐—ฝ ๐˜๐—ผ ๐—œ๐—˜๐—– ๐Ÿฒ๐Ÿฌ๐Ÿฒ๐Ÿฌ๐Ÿญ-๐Ÿญ, ๐Ÿฐ๐˜๐—ต ๐—ฒ๐—ฑโ“

IMDRF N47 & N52 both have been updated which will support Regulatory Submissions and Compliance Testing for the future of the IEC 60601 series including IEC 60601-1, 4th edition. ๐—œ๐— ๐——๐—ฅ๐—™ ๐—ฝ๐˜‚๐—ฏ๐—น๐—ถ๐˜€๐—ต๐—ฒ๐—ฑ two Final documents on ๐Ÿฎ๐Ÿฒ ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ, both to Version 2:
N47 Essential Principles of Safety and Performance of Medical Devices & IVD Medical Devices, and
N52 Principles of Labeling for Medical Devices and IVD Medical Devices

The ๐—ฝ๐˜‚๐—ฟ๐—ฝ๐—ผ๐˜€๐—ฒ ๐—ผ๐—ณ ๐—ก๐Ÿฐ๐Ÿณ ๐—ด๐˜‚๐—ถ๐—ฑ๐—ฎ๐—ป๐—ฐ๐—ฒ is to provide harmonized Essential Principles that should be fulfilled in the design & manufacturing of medical devices and in vitro diagnostic (IVD) medical devices to ensure that they are safe and perform as intended.  The worldwide adoption of a common set of fundamental design and manufacturing requirements for medical devices that, when met, provide assurance the device is safe and performs as intended, offers significant benefits to, among others, manufacturers, users, patients/consumers, and to Regulatory Authorities.  Reducing differences between jurisdictions decreases the cost of gaining regulatory compliance and allows patients earlier access to new technologies and treatments.

While ๐—ก๐Ÿฑ๐Ÿฎ ๐—น๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ๐˜€ ๐—ผ๐—ป ๐—ก๐Ÿฐ๐Ÿณ ๐—ฎ๐˜€ ๐—ถ๐˜โ€™๐˜€ ๐—ฝ๐˜‚๐—ฟ๐—ฝ๐—ผ๐˜€๐—ฒ states this guidance is to provide globally harmonized labeling principles for medical devices, including in vitro diagnostic (IVD) medical devices, and support N47.  Specifically, this document provides guidance on the content of the label, instructions for use, and information intended for the patient in order to support the safe and effective use of medical devices and IVD medical devices by their intended users.

With the ๐—œ๐—˜๐—– ๐Ÿฒ๐Ÿฌ๐Ÿฒ๐Ÿฌ๐Ÿญ-๐Ÿญ, ๐Ÿฐ๐˜๐—ต ๐—ฒ๐—ฑ๐—ถ๐˜๐—ถ๐—ผ๐—ป ๐—ฝ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜ underway ๐—ผ๐—ป๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐——๐—ฒ๐˜€๐—ถ๐—ด๐—ป ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฟ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€ – ๐—š๐—ผ๐—ฎ๐—น ๐Ÿฒ of the ๐—”๐—ฟ๐—ฐ๐—ต๐—ถ๐˜๐—ฒ๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

โ€œEstablish a policy relating requirements of the IEC 60601 series to the IMDRF essential principles and labelling principles.โ€
๐—š๐—ผ๐—ฎ๐—น ๐Ÿฒ ๐—ถ๐˜€ ๐—ฑ๐—ถ๐—ฟ๐—ฒ๐—ฐ๐˜๐—น๐˜† ๐—ฟ๐—ฒ๐—น๐—ฎ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—œ๐— ๐——๐—ฅ๐—™ ๐—ฑ๐—ผ๐—ฐ๐˜‚๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ก๐Ÿฐ๐Ÿณ ๐—ฎ๐—ป๐—ฑ ๐—ก๐Ÿฑ๐Ÿฎ ๐˜„๐—ต๐—ถ๐—ฐ๐—ต ๐˜„๐—ฒ๐—ฟ๐—ฒ ๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ป๐˜๐—น๐˜† ๐˜‚๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐—˜๐—ฑ๐—ถ๐˜๐—ถ๐—ผ๐—ป ๐Ÿฎ.

The Architecture Spec states:

โ€œIt is the ๐—ฝ๐—ผ๐—น๐—ถ๐—ฐ๐˜† ๐—ผ๐—ณ ๐—œ๐—˜๐—–/๐—ง๐—– ๐Ÿฒ๐Ÿฎ ๐˜๐—ผ ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ ๐—ฎ๐—ป ๐—ถ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฎ๐—ป๐—ป๐—ฒ๐˜… ๐—บ๐—ฎ๐—ฝ๐—ฝ๐—ถ๐—ป๐—ด the ๐—ฟ๐—ฒ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ต๐—ถ๐—ฝ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—œ๐— ๐——๐—ฅ๐—™ ๐—˜๐—ฆ๐—ฆ๐—˜๐—ก๐—ง๐—œ๐—”๐—Ÿ ๐—ฃ๐—ฅ๐—œ๐—ก๐—–๐—œ๐—ฃ๐—Ÿ๐—˜๐—ฆ ๐—ฎ๐—ป๐—ฑ ๐—Ÿ๐—”๐—•๐—˜๐—Ÿ๐—Ÿ๐—œ๐—ก๐—š ๐—ฃ๐—ฅ๐—œ๐—ก๐—–๐—œ๐—ฃ๐—Ÿ๐—˜๐—ฆ in ๐—ฒ๐—ฎ๐—ฐ๐—ต ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜€๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—œ๐—˜๐—– ๐Ÿฒ๐Ÿฌ๐Ÿฒ๐Ÿฌ๐Ÿญ ๐—ฆ๐—˜๐—ฅ๐—œ๐—˜๐—ฆ.โ€
This is a goal of IEC/TC 62.  For the IEC 60601-1, 4th edition project all Working Groups (WGโ€™s) are tasked to do this work in their WGโ€™s.  There are 12 WGโ€™s split up by hazards. In the future all standards that are developed by IEC/TC 62 should also follow this goal.
Another part of Goal 6 from the Architecture Spec states:
โ€œThe ๐—ฟ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐—บ๐—ฎ๐—ป๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜€๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐—˜๐—– ๐Ÿฒ๐Ÿฌ๐Ÿฒ๐Ÿฌ๐Ÿญ ๐—ฆ๐—˜๐—ฅ๐—œ๐—˜๐—ฆ are ๐—ถ๐—ป๐˜๐—ฒ๐—ป๐—ฑ๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ณ๐˜‚๐—น๐—ณ๐—ถ๐—น ๐˜€๐—ผ๐—บ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฟ๐—ถ๐—ป๐—ฐ๐—ถ๐—ฝ๐—น๐—ฒ๐˜€ set out ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐— ๐——๐—ฅ๐—™ ๐—ด๐˜‚๐—ถ๐—ฑ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฑ๐—ผ๐—ฐ๐˜‚๐—บ๐—ฒ๐—ป๐˜๐˜€. To facilitate the usage of the documents in the IEC 60601 SERIES for conformity assessment purposes by the AUTHORITIES HAVING JURISDICTION, it is important to ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—น๐˜† ๐—ถ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ฒ ๐˜„๐—ต๐—ถ๐—ฐ๐—ต ๐—œ๐— ๐——๐—ฅ๐—™ ๐—ฝ๐—ฟ๐—ถ๐—ป๐—ฐ๐—ถ๐—ฝ๐—น๐—ฒ๐˜€ ๐—ฎ๐—ฟ๐—ฒ ๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐˜„๐—ต๐—ถ๐—ฐ๐—ต ๐—ฟ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐—ฎ ๐˜€๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐—˜๐—– ๐Ÿฒ๐Ÿฌ๐Ÿฒ๐Ÿฌ๐Ÿญ ๐—ฆ๐—˜๐—ฅ๐—œ๐—˜๐—ฆ.โ€
This ๐—š๐—ผ๐—ฎ๐—น ๐Ÿฒ ๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜€ ๐˜๐—ต๐—ฒ ๐—œ๐— ๐——๐—ฅ๐—™โ€™๐˜€ ๐—ฐ๐—ผ๐—ป๐—ฐ๐—ฒ๐—ฝ๐˜ ๐—ผ๐—ณ ๐—ฒ๐—น๐—ถ๐—บ๐—ถ๐—ป๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—ฑ๐—ถ๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€ ๐—ฏ๐—ฒ๐˜๐˜„๐—ฒ๐—ฒ๐—ป ๐—ท๐˜‚๐—ฟ๐—ถ๐˜€๐—ฑ๐—ถ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ which ๐—ฑ๐—ฒ๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐˜€๐˜ ๐—ผ๐—ณ ๐—ด๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฒ from the various AUTHORITIES HAVING JURISDICTION (AHJ) and allows ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐—ฒ๐—ฎ๐—ฟ๐—น๐—ถ๐—ฒ๐—ฟ ๐—ฎ๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€ ๐˜๐—ผ ๐—ป๐—ฒ๐˜„ ๐˜๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐˜๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜๐˜€.  This is a positive impact on patients and also makes for an easier process for the manufacturers and for the AHJโ€™s, as well.

When IEC TC 62/SC 62A/WG 39 met in Arlington, VA on 1- 2 May 2024 this was brought up during the meeting, as this is an important issue that needs to be addressed during the IEC 60601-1, 4th edition project. One aspect WG 39 is dealing with is โ€œInformation to be supplied by the manufacturerโ€ (i.e. Labeling).  This is the IEC 60601-1, 4th edition WG that I am a co-convener of. There are lots of changes happening in the standards and regulatory world around labeling and we are working hard to keep informed on all these changes that will impact this project. ๐—ฆ๐˜๐—ฎ๐˜† ๐˜๐˜‚๐—ป๐—ฒ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜‚๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐˜€โ€ผ๏ธ

Need help with 60601 series standards (Medical Electrical Equipment) including EMC; training to 3rd or 4th edition; strategic planning for your medical electrical product lines; need support when FDA or a regulator asks questions for a submission Eisner Safety Consultants experts deal with EU, US, & other country regulatory requirements & standards, laws, directives, and more. Leo Eisner is an expert on standards development and sits on many standards committees. He also has experts on additional standards committees and we all talk to the regulators. He has a team of experts to support your needs.

We work with many test labs for Medical Electrical Safety & EMC and can arrange other testing, as well. Please let us know if we can help when you contact us.

Feel free to schedule a call with Leo or contact Leo at  or through our contact form.

Whatโ€™s The Relationship of Updated IMDRF N47 & N52 to IEC 60601-1, 4th ed?